About us
Investor Relations
Fact Sheet
Products & Services
Support
Animal Welfare
Events
Career
Visit our main locations

Canada / Denmark / Hungary
 Events
Seminar: Practical Approaches to Dosing Route Challenges in Non-clinical Research
SOT 2009
Monday, 16 March 2009
 

SOT 2009, Baltimore, MD. Booth # 2815 (Mar15-19)
 

Subscribe to our Mailing list!
 Customer service
1-888-353-2240    
Document center   
Inquiry form   
Client center   

Fact Sheet 

 

Q2 2008 Highlights

    • Record revenue of $16.1 million
    • Net earnings of $0.7 million
    • Earnings per share of $0.04
    • Expansion: Phase I completed for all sites.  Phase III completed Q4 2008 in Canada and early 2010 in Denmark.

 

Investor Information

  • TSX Symbol: LRI
  • Shares Outstanding: 18M
  • Fully Diluted: 19.3M
  • Market Cap. August 21, 07: $139M
  • Year-end: December 31st

Ownership

  • Management: 1%
  • Institutions: ≈ 85-89%
  • Retail: ≈ 10 -14%

 

Management Team

  • Luc Mainville, President and CEO
  • Louise Bussières, Vice-President, Finance
  • Andy Makin, Managing Director, Denmark
  • Christopher Banks, Managing Director, Hungary
  • Denis Pilon, Chief Operating Officer, Canada

First 6 Months 2008 Highlights

  • $31.5 million revenue
  • $1.3 million net earnings
  • $0.07 earnings per share
 Stock quotes

 News  LAB Research News archives
LAB Research Announces its 2008 Third Quarter Financial Results
 

LAB Research to Hold Third Quarter 2008 Financial Results
 

 Investor relations
Dominic Sicotte
1.866.633.9551, ext. 101
dsicotte@echoesfinancial.com
     
Français | Home | About | Investor Relations | Careers | Corporate Profile | Products | Animal Welfare | Events | Customers Services
Copyright © 2006 LAB Research Inc. All Rights Reserved | Data Privacy Policy